Natural Beauty Bio-Technology Limited (HKG:0157)
Hong Kong · Delayed Price · Currency is HKD 0.4600
-0.0050 (-1.08%)
Jul 31, 2026, 3:55 PM HKT
HKG:0157 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 921 | 981 | 971 | 961 | 1,101 | 1,101 | |
Market Cap Growth | -13.21% | 1.03% | 1.04% | -12.73% | 0% | -15.38% |
Enterprise Value | 1,123 | 1,102 | 1,041 | 983 | 1,037 | 1,038 |
Last Close Price | 0.46 | 0.49 | 0.48 | 0.48 | 0.55 | 0.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 87.06 | 92.72 | - | - | - | 31.23 |
Forward PE | - | 31.11 | 31.11 | 31.11 | 31.11 | 31.11 |
PS Ratio | 1.71 | 1.82 | 2.75 | 2.86 | 3.28 | 2.26 |
PB Ratio | 1.94 | 2.07 | 2.17 | 1.67 | 1.84 | 1.67 |
P/TBV Ratio | 1.94 | 2.07 | 2.17 | 1.75 | 1.93 | 1.77 |
P/FCF Ratio | - | - | - | - | - | 169.30 |
P/OCF Ratio | - | - | - | 44.24 | 95.27 | 24.68 |
PEG Ratio | - | 1.62 | 1.62 | 1.62 | 1.62 | 1.62 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.08 | 2.05 | 2.94 | 2.93 | 3.09 | 2.13 |
EV/EBITDA Ratio | 17.21 | 19.08 | - | 45.93 | 224.76 | 14.41 |
EV/EBIT Ratio | 42.44 | 40.28 | - | 2356.75 | - | 22.50 |
EV/FCF Ratio | - | - | - | - | - | 159.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.67 | 0.67 | 0.47 | 0.32 | 0.24 | 0.20 |
Debt / EBITDA Ratio | 4.83 | 4.83 | - | 6.88 | 9.58 | 1.59 |
Debt / FCF Ratio | - | - | - | - | - | 19.85 |
Net Debt / Equity Ratio | 0.43 | 0.43 | 0.21 | 0.03 | -0.04 | -0.10 |
Net Debt / EBITDA Ratio | 3.50 | 3.50 | -4.03 | 0.81 | -5.82 | -0.94 |
Net Debt / FCF Ratio | -2.41 | -2.41 | -1.69 | -0.37 | 0.82 | -10.39 |
Asset Turnover | 0.63 | 0.63 | 0.43 | 0.39 | 0.37 | 0.55 |
Inventory Turnover | 2.79 | 2.79 | 1.91 | 1.54 | 1.34 | 1.62 |
Quick Ratio | 0.75 | 0.75 | 1.02 | 0.89 | 1.00 | 1.32 |
Current Ratio | 1.11 | 1.11 | 1.54 | 1.21 | 1.46 | 1.89 |
Return on Equity (ROE) | 2.30% | 2.30% | -20.27% | -2.58% | -4.86% | 5.56% |
Return on Assets (ROA) | 2.01% | 2.01% | -3.75% | 0.03% | -1.34% | 3.27% |
Return on Invested Capital (ROIC) | 3.62% | 4.03% | -8.71% | 0.07% | -3.33% | 6.04% |
Return on Capital Employed (ROCE) | 4.50% | 4.50% | -8.40% | 0.10% | -3.10% | 6.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.15% | 1.08% | -10.67% | -1.57% | -2.77% | 3.20% |
FCF Yield | -9.09% | -8.54% | -5.66% | -4.93% | -2.97% | 0.59% |
Dividend Yield | - | - | - | - | - | 0.55% |
Payout Ratio | - | - | - | - | - | 17.03% |
Total Shareholder Return | - | - | - | - | - | 0.55% |